The method 9, wherein said {HEAD ~ oral administration} is characterized by {TAIL ~ substantially no increase} in serum levels of aspartate aminotransferase , alanine aminotransferase , or both 
is characterized by
The method 9 , wherein said { HEAD ~ oral administration } is characterized by { TAIL ~ substantially no increase } in serum levels of aspartate aminotransferase , alanine aminotransferase , or both
OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL REL REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH